Among all, CpG3 of ZNF471 promoter had the predominant prognostic role for gastric cancer patients with the most significant P value (HR 2.616; 95% CI: 1.491–4.590; P = 0.001) (Table 1). This evidence concerns the gene ZNF471 and gastric cancer.